Technology & Innovation
day one project

Scaling High-Impact Solutions with a Market-Shaping Mechanism for Global Health Supply Chains

04.06.23 | 12分钟阅读 | Text byAmanda Arch&Shiro Wachira&Jay Sullivan&约书亚·舒普(Joshua Schoop)

Summary

Congress created the Development Finance Corporation (DFC) to finance private sector solutions to the most critical challenges facing the developing world. In parallel, the United States Agency for International Development (USAID) has committed toengaging the private sectorand shifting more resources to local market providers to further the impact of U.S. foreign aid dollars.

USAID is on the verge of awarding its largest-ever suite of foreign aid contracts, totaling $17 billion over the next ten years and comprising nine awards as part of the “NextGen Global Health Supply Chain” (GHSC) contracts. This is a continuation of previous global health supply chain contracts that date back to the 1960s that have grown exponentially in total value but have underperformed and not meaningfully transitioned responsibility for deployment to low- and middle-income country (LMIC) governments and LMIC-based organizations.

Now is the time for USAID and the DFC to pilot new ways of working with the private sector that put countries on a path to high-impact, sustainable development that builds markets.

We propose that USAID set aside $300 million of the overall $17 billion package – or less than 2 percent of the overall value – to create a Supply Chain Commercialization Fund to demonstrate a new way of working with the private sector and administering U.S. foreign aid. USAID and the DFC can deploy the Commercialization Fund to:

USAID and the DFC can pilot this new model in three countries where there are alreadythriving and well-established private markets, like Ghana, Kenya, and Nigeria.

Challenge and Opportunity

The world is facing an unprecedented concurrence of crises: pandemics, war, rising food insecurity, and a rapidly warming climate. Low- and middle-income countries (LMICs) are deeply affected, with many having lost decades’ worth of gains made toward the Sustainable Development Goals in only a few short years. We now face the dual tasks of regaining lost ground while ensuring those gains are more durable and lasting than before.

The Biden Administration recognizes this pivotal moment in its newU.S. Strategy Toward Sub-Saharan Africa。该战略承认大陆的成长g importance to U.S. global priorities and lays out a 21st-century partnership to contribute to a strong and sustainable global economy, foster new technology and innovation, and ultimately support the long-envisioned transition from donor-driven to country-driven programs. This builds on past U.S. foreign aid initiatives led by administrations of both political parties, including Administrator Mark Green’s Journey to Self Reliance and Administrator Raj Shah’s USAID Forward initiatives. Rather than creating a new flagship program, the U.S. Strategy Toward Sub-Saharan Africa focuses on improved implementation and better integration of existing initiatives to supercharge results. Such aims wereechoed repeatedlyduring the U.S.-Africa Leaders Summit in December 2022.

To realize a new vision for U.S.-Africa partnerships, the Biden Administration should more effectively fuse the work of USAID and the DFC. A keypolicy rationalefor the DFC’s creation in 2018 was to counter China’s Belt and Road Initiative (BRI) and growing economic influence in frontier markets. By combining this investment arm with USAID’s programmatic work, Congress hoped to accelerate major development impact. Howevernumerous mismatches between USAID and DFC prioritieshave limited and sometimes actively undermined Congress’ goals. In the worst cases, USAID dollars have been used to pay international aid contractors to perform work in places where existing market providers could. Rather than bolster markets, this candistortthem.

This memo lays out a new approach to development rooted in better USAID-DFC collaboration, where the work of both agencies contributes to the commercialization of sectors ready to transition from aid-dependent models to commercial and trade-enabled ones. In these sectors, USAID should work to phase out its international aid contractor-led model and instead scale up the work of existing market participants, including by paying them for results. This set of recommendations also advances USAID priorities outlined in the Agency’s newAcquisition and Assistance Strategyand proposedimplementation plan, as well as USAID’s政策框架, which each call for working more closely with the private sector and transitioning to more pay-for-performance models.

The global health supply chain is ideal for USAID and the DFC to test the concept of a commercialization fund because of the sector’s discrete metrics and robust existing logistics companies. Investing in cheaper, more efficient evidence-driven solutions in a competitive marketplace can improve aid effectiveness and better serve target populations with the health goods like PPE, vaccines, and medications they need. This sector receives USAID’s largest contracts, with the Agency spending more than $1B each year on procurement and logistics to get the right health products to the right place, at the right time, and in the right condition across dozens of countries. In the logistics space, only about 25%1of USAID’s expenditure supports directly distributing commodities to health facilities in target nations; the other 75% is spent on fly-in contractors who oversee that work. Despite this premium, on-time and in-full distribution rates often miss their targets, and stockouts are still common, according to USAID’s reports and audits.2

A Commercialization Fund can directly address policy goals such as localization or private-sector engagement by building resilient health supply chains through a marketplace of providers that ensures patients and providers access the supplies they need on time. In addition to improving sustainability and results and cutting costs, a well-structured Commercialization Fund can improve global health donor coordination, crowd-in new investments from other funders and philanthropy that want to pay for outcomes, and hasten the transition from donor-led aid models to country-led ones.

Plan of Action

USAID should create the Global Health Supply Chain Commercialization Fund, a $300 million initiative to purchase commercial supply chain services directly from operators, based on performance or results. USAID should pilot using the Commercialization Fund to pay providers in three countries where there arealready thriving and well-established private logistics markets, such as Kenya, Nigeria, and Ghana. In these countries, dozens of logistics and healthcare providers operate at scale, serving millions of people.

最初关注健康物流,美国国际开发署应从其尚未获得的170亿美元的NextGen全球健康供应链合同中使用3亿美元,以为商业化基金提供初始资金。如果成功的话,商业化基金将在全球卫生供应链中为竞争和人群的高影响力技术,创新以及更多基于市场的参与者创造一个开放的竞争环境。该基金将基于整个机构的现有努力,以识别,孵化和催化私营部门的创新。

To quickly stand up this Commercialization Fund and select vendors, Administrator Power should utilize her “impairment authority。” Though typically applied to emergencies, the “impairment authority” has been used previously during global health events like the COVID-19 pandemic and the Ebola response and could be used to achieve a specific policy priority such as localization and/or transforming the way USAID administers its global health supply chains. (See FAQ for more information regarding this authority).

The creation of this Fund, which can be fully budget-neutral, requires the following steps:

Step 1. USAID and DFC take administrative action to design and capitalize the $300 million, five-year, cross-cutting, and disease-agnostic Supply Chain Commercialization Fund.A joint aid effectiveness “tiger team” within USAID and the DFC should:

  1. Spearhead the design and implementation framework for the Fund and stipulate clear, standardized key performance indicators (KPIs) to indicate significant improvements in health supply chain performance in countries where the Commercialization Fund operates.
  2. Select three countries to adopt the Commercialization Fund, chosen in coordination with overseas USAID Missions and the DFC. Countries should be selected and prioritized based on factors such as analyses of health systems’ needs, the existence of local supply chain service providers, and countries’ desire to manage more of their own health supply chains.作为美国 - 非洲领导人峰会的后续访问,我们建议美国国际开发署和DFC直接的初始商业化基金资金来支持非洲的活动,那里已经有蓬勃发展且已建立了良好的私人市场,例如加纳,肯尼亚和尼日利亚。
  3. Set pricing for each KPI and product in each Commercialization Fund country market. For example, pay-for-performance indicators could include percent of on-time deliveries. USAID and the DFC should set high expectations for performance, such as 95+ percent on-time delivery, especially in geographies where existing market providers can already deliver against similarly rigorous targets in other sectors. USAID bureaus and missions, partner country governments, and in-country private sector healthcare and logistics leaders, as well as supply chain and innovative financing experts, should be consulted during this process.
  4. 选择为结果支付的资金机制(有关详细信息,请参见步骤2)。
  5. Provide blended financing to vendors that may need additional resources to scale their footprint and/or increase their capabilities.
  6. Select a third-party auditor(s) to audit the results upon which providers are paid.

Step 2: USAID structures financial instruments to pay service providers against results delivered in selected Commercialization Fund countries

USAID should pay Commercialization Fund providers to deliver results, consistent with the KPIs set in Step 1 by the joint aid effectiveness “tiger team.” Pay-for-performance contracts can also provide incentives and/or price assurances for service providers to build infrastructure and expand to areas they don’t traditionally serve.

Structuring pay-for-performance tools will favor providers that can demonstrate their ability to deliver superior and/or more cost-effective results relative to status quo alternatives. Preference should be given to providers that are operational in the target country where there is existing market demand for their services, as evidenced by factors such as whether the host country government, national health insurance program, or consumers already pay for the providers’ services. USAID should work with the host country government(s) to select vendors to ensure strong country buy-in.

To maximize performance and competition, USAID should explicitly not use cost-reimbursable payment models that reimburse for effort and optimize for compliance and reporting. The red tape associated with these awards is so cumbersome that non-traditional USAID service providers cannot compete.3

USAID should consider using the following pay-for-performance modalities:

Step 3: USAID and DFC should provide countries with additional technical assistance resources to create intentional pathways for selected countries to contribute to the design and management of program implementation.

To ensure these initiatives support countries’ needs and facilitate country ownership and increase voice, USAID should also consider establishing a supra-agency advisory board to support the success of the Commercialization Fund modeled afterDFC的非洲投资顾问计划that seats a panel of experts that can continually advise both agencies on strategic priorities, key risks, and award structure, etc. It could also model elements of the Millennium Challenge Corporation’scompact modelto ensure participating countries have a hand in the design of relevant aspects of the Commercialization Fund.

USAID should additionally provide participating Commercialization Fund countries with Technical Assistance resources to ensure that host country governments can eventually take on larger management responsibilities regarding the administration of Commercialization Fund pay-for-performance contracts.

Step 4: As needed, USAID and the DFC should collaborate to provide sustainable pathways for blended financing that allows existing market providers to access working capital to scale their footprint.

While the DFC and USAID have worked on blended finance deals in the past, the Biden Administration should explicitly direct the two agencies to work together to identify and scale the footprints and capabilities of logistics and healthcare providers in targeted Commercialization Fund countries.

Many of the existing healthcare and logistics providers that could potentially manage a greater share of global health supply chains could need additional financing to expand their operations, increase working capital, or grow their capabilities, but they often find themselves in a chicken or the egg problem to secure financing from financial institutions like the DFC.

Traditional banks and DFC investment officers often consider these companies to be potentially risky investments because their revenue in health supply chains is not assured, especially because one of the largest healthcare payers in many LMICs is the U.S. Government, but USAID (and other global health donors) have historically funded international aid contractors to manage countries’ health supply chains, not local firms or alternative service providers. However, at the same time, USAID and other donors have not relied more on existing logistics service providers to manage health supply chains because many of these providers do not operate at the scale of larger international aid contractors.

To break this cycle, and to enable the DFC and other lenders to offer better financing terms to firms that need it to grow their capabilities or secure working capital, USAID could provide identified firms with more blended finance deals, including guaranteed eligibility to receive pay-for-performance revenue using the funding modalities described above. It could also provide unrestricted early-stage and/or phased funding to cover operational costs associated with working with the U.S. Government.

增加可用的信贷公司通过DFCnd using a USAID pay-for-performance contract as collateral would also enhance firms’ overall ability to raise credit from other sources. This assurance, in turn, reduces the cost of capital for receiving firms, resulting in more significant, impactful investments from private capital in the construction of other supply chain infrastructure, including warehouses, IT systems, and shipping fleets.

步骤5:待定成功,美国国际开发署和DFC应在其他国家 /地区复制商业化基金。国会应将商业化基金定为法律,并授权在2025年重新授权的其他地理和部门中大规模的商业化基金。

While this initial Commercialization Fund will focus on building sustainable, high-performing global health supply chains in three LMICs, the same blueprint could be leveraged in other countries and in other sectors where there are robust private sectors, such as in food or power.

  1. Congress should require USAID and DFC to report overall Commercialization Fund performance every six months for a minimum of three years.
  2. If the Commercialization Fund proves successful after the first year, USAID and the DFC should proactively invite other countries to participate to expand this model to other geographies, where appropriate.
  3. If successful with healthcare supply chains, the Commercialization Fund should also be expanded to cover additional sectors and geographies and included in the BUILD Act 2025 reauthorization.

Conclusion

Continued reliance on traditional aid in commercial-ready sectors contributes to market failures, limits local agency, and minimizes the opportunity for sustainable impact.

As a team of researchers from the Carnegie Endowment’s Africa Programpointed out在美国 - 非洲领导人峰会之后,“对非洲的一种持续的人道主义方法……创造了无助的依赖性的病理学,对包容性增长的驱动因素的关注不足,并通过一个相互联系的小伙子来继续进行现状受益人。”这些研究人员确定了在峰会上宣布的18项新举措,并在经济部门的公共资金支持的峰会上宣布,这些倡议可以促进贸易,投资,企业家精神和创造就业机会,这表明了该政府在该政府中的前所未有的准备就绪,以优先考虑贸易。

The Commercialization Fund outlined in this memo — a market-shaping mechanism designed to correct market failures that conventional aid models can perpetuate — has the potential to become a model for accelerating the transition of other key economic sectors away from the status quo and toward innovation, investment, impact, and long-term sustainability.

Frequently Asked Questions
Why focus on global health supply chains?

The global health supply chain is an ideal sector for USAID and the DFC to test the concept of a Commercialization Fund:



首先,几乎每一个行业依靠强劲的年代upply chains to get goods around the world. There are dozens of African logistics companies that deliver goods to last-mile communities every day, including hard-to-transport items that require cold-chain storage like perishable goods and vaccines. These firms can deliver health commodities faster, cheaper, and more sustainably than traditional aid implementers, especially to last-mile communities.


Second, health supply chain performance metrics are relatively straightforward and easy to define and measure. As a result, USAID can facilitate managed competition that pays multiple logistics providers against rigorous, predetermined pay-for-performance indicators. To provide additional accountability to the taxpayer, it could withhold payment for factors such as health commodity spoilage.


Third, global health receives the largest share of USAID’s overall budget, but a significant share of those resources pay for contractor overhead and profit margin, so there is considerable opportunity to re-allocate those resources to create a pay-for-performance Supply Chain Commercialization Fund. Only about 25 percent美国国际开发署的国内物流支出为将商品分配给目标国家的卫生设施的实际工作;其他75%的费用支付了更大的援助承包商的间接费用,管理和其他费用。尽管如此,根据美国国际开发署的报告和审计,尽管有这种溢价,但按时和满足分配率通常会错过其目标,而且库存仍然是一个普遍的情况。ReportsReports


Investing in cheaper, more efficient, and effective operators in a competitive marketplace can improve aid effectiveness and better serve target populations with essential healthcare. A Commercialization Fund can directly address policy goals of “progress over programs” by building resilient health supply chains that, once and for all, ensure patients and providers get the supplies they need on time. Since local providers can typically provide services faster, cheaper, and more sustainably than international aid contractors, transitioning to models that pay for results with fees set to prevailing local rates can also advance USAID’slocalizationpriorities and bolster markets rather than distort them.

What is “impairment authority” and how could Administrator Power use it to create the Fund and ensure it supports outcomes-driven work regardless of organization size?

管理员可以激活她独特的“impairment authority” to fashion the scope of procurement competitions at will. The fundamental concept is that if full and open competition for a contract or set of contracts—the normal process followed to fulfill the U.S. Government’s requirements—would impair foreign assistance objectives, then the administrator can divide procurements falling under the relevant category to advance an objective like localization. This authority, which is codified in USAID’s core authorizing legislation (the Foreign Assistance Act of 1961, as amended), along with a formal U.S. Government regulation, was previously used to quickly procure during Iraq reconstruction, Afghanistan humanitarian needs, and the Ebola and COVID-19 responses. While “impairment authority” may be an untested pathway for global health supply chains, it does offer the administrator a viable pathway to launch the Fund and ensure high-impact operators are receiving USAID contracts while continuing to consult with Congress to codify the Fund’s activities long-term. The administrator’s extraordinary “impairment authority” comes from 636(a)(3) of the Foreign Assistance Act and AIDAR (the USAID-specific Supplement to the FAR) Section 706.302-70 “Impairment of foreign aid programs.” See especially 706.302-70(a)(3)(ii).

How do we know countries want to work with next-generation and alternative supply chains, services, and companies, rather than traditional international aid contractors?

许多LMIC政府越来越多地采用传统援助模型之外的技术解决方案,因为他们知道技术可以提高效率,支持就业机会和经济发展,并为其人口带来改善的结果。维持一个国家或地区内的市场是支持该行业中新进入者和现有公司的优势。The impact of these companies’ services can also be scaled via pay-for-results models and domestic government spending, as the firms that deliver superior performance will rise to the top and continue to be demanded, and those that do not meet established metrics will not be contracted with again.

Who should be consulted outside of the federal government to ensure the Commercialization Fund is successful and focused on the right supply chains and technologies?

深入了解困扰全球卫生供应链的挑战的供应链和创新融资专家应咨询设计成功的薪资型汽车。这些人应支持USAID/DFC Tiger团队支持商业化基金的设计和实施框架,定义KPI,设定适当的定价和精选审计师。美国国际开发署的任务和地方政府将最熟悉其司法管辖区的独特供应链挑战,并应与供应链专家一起工作,以确定其国家的商业化基金所需的供应链结果。

How are data- and evidence-driven policy integrated into the Commercialization Fund?

通过商业化基金,美国国际开发署将会反对tract any supply chain service provider that can meet exceptionally high performance targets set by the Agency. USAID will increase its volume of business with providers that consistently hit relevant targets over consecutive months. Operators will be paid based on their performance under these contracts, providing them with predictable and consistent cash flows to grow their businesses and reach system-wide scale and impact. Based on these anticipated cash flows, DFC will be well-positioned with equity investments and able to provide upfront and working capital financing.


As the highest-performing operators scale, they gain cost efficiencies that allow them to lower their pricing, just as with any technology adoption curve making services accessible to more customers. Over time, as clear pricing and operating standards are realized, USAID will transition from directly paying these operators for performance to supporting governments to remunerate them against transparent, auditable service contracts.


The Supply Chain Commercialization Fund will also facilitate an exchange of expertise, greater interagency learning, and long-term coordination. DFC will share with USAID how to commercialize sectors, transition them from aid to trade, and lay the groundwork for DFC deal flow, while USAID will help DFC evaluate smaller, riskier deals in sectors with fewer commercial entrants. Both institutions can use the Fund to align on clear measures of success through USAID’s contracting directly with supply chain service providers that get paid only if they hit exceptionally high performance targets and DFC’s increasing investment in companies based on their development effectiveness.

How can USAID ensure that transitioning to new partners does not create new risks that result in supply chain disruptions?

The risk of supply chain disruptions is low because the initial three countries proposed—Kenya, Ghana, and Nigeria—already have existing African-based logistics providers that provide essential health commodities to communities every day, including in last-mile and low-resourced settings. Many of these providers deliver products faster, cheaper, and more sustainably than international aid donor-funded distributors. The capacity-building fund mechanisms described above can also mitigate risks to ensure firms have the capital investment to scale their existing work to meet contract requirements.

How will the Fund’s impact be measured during and after the program?

USAID should hire third-party auditors to verify the impact and results of Fund investments. We anticipate the Agency should draw from Commercialization Fund resources to pay for these services.

Why $300 million?

虽然3亿美元不到全球整体健康供应链奖励套件的不到2%,但这项承诺将在多年期间为合作伙伴国家的公司提供重要的长期市场信号。它还将提供足够的资金来扩展选定的公司并展示新的供应链资金模型如何运作。

1
NextGen国内物流RFP PG。198抛出了3.78亿美元的“所有2PL和3PL分包成本的插头数字”,RFP状态为基于历史采购”。此插头数字仅占$ 1.5B总合同价值的25%。
2
See, for example, findings from the Global Fund Audit of Grants in the Republic of Ghana (2019) and USAID Ghana National Supply Chain Assessment (2020). The supply chain performance issues documented in these reports include just 30% of orders being delivered in full, $1 million in expired drugs being stored at 30 warehouses surveyed, 30+ day stockouts of key commodities reported at 70% of facilities, just 40% of RMSs recording any transportation and delivery data, 63% of facilities having inaccurate stock cards, and a 21-day delay between commodity consumption and reporting by the GHS.
3
Cost-reimbursement models limit impact and competition at other federal agencies, too. NASA Administrator Bill Nelson told Congress they were a “plague” on the agency he runs because these award vehicles drive up costs, stifle innovation, and limit competition.https://spacenews.com/nelson-criticizes-plague-of-cost-plus-nasa-contracts/